Effect of Interleukin Beta and Resistin on Development of Cardiomyopathy in Type 2 Diabetes

dc.contributor.authorZhuravlyova, Larysa
dc.contributor.authorSokolnikova, Nelia
dc.contributor.authorMohammed, Kassim
dc.date.accessioned2020-05-30T16:39:14Z
dc.date.available2020-05-30T16:39:14Z
dc.date.issued2020
dc.description.abstractType 2 diabetes occurs when our body becomes resistant to insulin and pancreas produce more insulin to compensate and later pancreas becomes decompensated.Type 2 diabetes is major risk factor for cardiovascular disease.en_US
dc.identifier.citationKassim M. Effect of Interleukin Beta and Resistin on Development of Cardiomyopathy in Type 2 Diabetes / M. Kassim, N. Sokolnikova, L. Zhuravlyova // Juvenes Pro Medicina : 16th International and 58th Polish Conference, Lodz, 15–16th may 2020 : The Book of Abstracts. – Lodz, 2020. – P. 297.en_US
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/26131
dc.language.isoenen_US
dc.subjectcardiomyopathyen_US
dc.subjectdiabetes mellitus type 2en_US
dc.subjectInterleukin 1βen_US
dc.titleEffect of Interleukin Beta and Resistin on Development of Cardiomyopathy in Type 2 Diabetesen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Interleukin 1-Beta.pdf
Size:
547.58 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
11.22 KB
Format:
Item-specific license agreed upon to submission
Description: